Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453141 · ClinicalTrials.gov registry record · NA
Betamethasone Dosing Interval - 12 or 24 Hours?
A NA study, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00453141: Completed NA study, sponsored by The Cooper Health System.
NCT00453141 is a NA study that has completed, run by The Cooper Health System. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453141, a NA study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart.
Interventions
- DRUG dosing of Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00453141 record still lists
NCT00453141 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which dosing of Betamethasone is the first listed.
NCT00453141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00453141 about?
NCT00453141 is a clinical study titled "Betamethasone Dosing Interval - 12 or 24 Hours?". The purpose of this study is to determine if there may be a benefit to the newborn if betamethasone is given 12 hours apart instead of 24 hours apart.
What is the current status of trial NCT00453141?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2006-04. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00453141?
The interventions under investigation include: dosing of Betamethasone (DRUG).
Who is sponsoring clinical trial NCT00453141?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00453141's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia